308 related articles for article (PubMed ID: 15041331)
1. Immunosuppression in kidney transplantation in Poland.
Paczek L; Lao M; Durlik M; Szmidt J; Rowinski W
Transplant Proc; 2004 Mar; 36(2 Suppl):173S-176S. PubMed ID: 15041331
[TBL] [Abstract][Full Text] [Related]
2. Application of cyclosporine in renal transplantation: experience at the University of Padua.
Furian L; Baldan N; Rigotti P
Transplant Proc; 2004 Mar; 36(2 Suppl):148S-151S. PubMed ID: 15041326
[TBL] [Abstract][Full Text] [Related]
3. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S
Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332
[TBL] [Abstract][Full Text] [Related]
4. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
Konstadinidou I; Boletis JN
Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
6. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
[TBL] [Abstract][Full Text] [Related]
7. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.
Oberbauer R; Segoloni G; Campistol JM; Kreis H; Mota A; Lawen J; Russ G; Grinyó JM; Stallone G; Hartmann A; Pinto JR; Chapman J; Burke JT; Brault Y; Neylan JF;
Transpl Int; 2005 Jan; 18(1):22-8. PubMed ID: 15612979
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
9. The impact of cyclosporine on the development of immunosuppressive therapy--pediatric transplantation using cyclosporine.
Hoyer PF; Vester U
Transplant Proc; 2004 Mar; 36(2 Suppl):197S-202S. PubMed ID: 15041336
[TBL] [Abstract][Full Text] [Related]
10. Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients.
Di Paolo S; Teutonico A; Infante B; Stallone G; Schena A; Grandaliano G; Battaglia M; Di Tonno P; Schena FP
Transplant Proc; 2004 Mar; 36(2 Suppl):434S-436S. PubMed ID: 15041381
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive protocols at transplantation centers in Turkey.
Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
[No Abstract] [Full Text] [Related]
12. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
He X; Johnston A
Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
[TBL] [Abstract][Full Text] [Related]
13. Experience with cyclosporine in the Canary Islands.
Hernández D
Transplant Proc; 2004 Mar; 36(2 Suppl):120S-124S. PubMed ID: 15041320
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the use of cyclosporine in renal transplantation.
Yoshimura N; Okamoto M; Akioka K; Kaihara S
Transplant Proc; 2004 Mar; 36(2 Suppl):181S-185S. PubMed ID: 15041333
[TBL] [Abstract][Full Text] [Related]
15. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
[No Abstract] [Full Text] [Related]
17. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.
Sommerer C; Konstandin M; Dengler T; Schmidt J; Meuer S; Zeier M; Giese T
Transplantation; 2006 Nov; 82(10):1280-5. PubMed ID: 17130775
[TBL] [Abstract][Full Text] [Related]
18. Renal allograft function and histology in children on triple immunosuppression based on individual pharmacokinetically determined cyclosporine administration.
Laine J; Hoppu K; Holmberg C
Transplant Proc; 1994 Oct; 26(5):2775-6. PubMed ID: 7940874
[No Abstract] [Full Text] [Related]
19. Rational clinical regimens for kidney transplant immunosuppression.
Belitsky P
Transplant Proc; 1994 Oct; 26(5):2485-9. PubMed ID: 7940763
[No Abstract] [Full Text] [Related]
20. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
